VIP36, a new CB1 agonist, targets a cryptic pocket to provide analgesia for chronic pain while minimizing side effects and ...

The idea of a “dessert stomach” isn’t just a joke — it’s science. Researchers found that the same brain cells that make you ...

U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...

GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.

March 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused ...

The drug is a selective NaV1.8 pain signal inhibitor and has been cleared to treat adults ... Stauffer pointed out that many of the research efforts being put into novel mechanisms and non-opioid ...

And recently, she was the youngest participant in Duke University’s MaryAnn Black Distinguished Health Equity Symposium 2025 where she delivered a presentation on opioid overdose education and ...

At issue: whether opioid settlement money — paid by health care companies that were sued for fueling the opioid crisis and meant to help states abate addiction — should be funneled to two ...

Blocking opiate signaling in this pathway could support current and future obesity treatments. Why do we crave sugary snacks on full stomach? To find out more about the brain's unique mechanism ...

The same nerve cells responsible for signaling fullness after a meal also play a role in triggering a craving for sweets. In both mice and humans, simply perceiving dessert activates this pathway, ...